|
|
|
|
Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024
2To whom correspondence should be addressed. E-mail: mneuhous{at}fhcrc.org.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: dietary supplements vitamins minerals nutrition surveys epidemiologic methods
Dietary supplement use by American women has increased considerably in the past 10 y. Population-based surveys conducted among U.S. adults show that in the early 1990s about 25% of women reported regular supplement use, which increased to over 50% by the end of the decade (15). At least two factors account for this large increase over a short period. First, research findings published throughout the past 1020 y have established that some supplements are very effective for disease prevention and their use has become a part of routine clinical practice [e.g., folic acid during the periconceptional period to reduce the risk of neural tube defects (6) and iron to prevent or treat anemia during pregnancy (7,8)]. Second, Public Law 103417, the Dietary Supplement and Health Education Act (DSHEA) passed in 1994 (9) resulted in an exponential increase in the number and variety of supplements available for over-the-counter purchase. Specifically, DSHEA expanded the definition of dietary supplements to include ingredients not known to be required for human nutrition (i.e., herbs, glandular extracts), discontinued premarket safety evaluations for ingredients used in supplements, placed the burden of proof of product safety on the U.S. Food and Drug Administration (FDA) instead of the manufacturers and permitted limited nutrition support statements without prior approval from the FDA (9).
Very little is known about the risks and benefits of long-term and widespread supplement use. Investigating the consequences of this health behavior in American women has been identified as an important area of research (10). To this end an important task is to examine the current patterns of dietary supplement use in American women. The objective of this report is to describe the types of supplements used by adult American women, demographic characteristics associated with supplement utilization, motivations for use and economic effects. The information presented in this and other reports in this issue will be used to develop a focused research agenda for dietary supplement use in adult American women.
| Methodological issues related to collection of supplement use data |
|---|
|
|
|---|
| Definition of dietary supplements |
|---|
|
|
|---|
Many supplements are complex mixtures of as many as 20 or more micronutrients, botanical extracts and other biological materials, and no consensus exists among researchers on how to code these types of products. Because the number and type of nonvitamin and nonmineral supplements will likely increase over the next several years, expansion of the current DSHEA definition to include classification of these products could help researchers to uniformly collect and code these data.
| Exposure assessment: frequency and duration of supplement use |
|---|
|
|
|---|
As a result of both increased supplement use in the 1990s and the recognition that supplement use may be an important exposure for disease risk, scientists have developed more detailed data collection methods that include quantitative questions on dosages of micronutrients, duration of use (e.g., weeks, months, years) and frequency of use (e.g., daily, weekly) (1,17,18). Despite these improvements in study design, data collection methods still vary widely across studies. For example, the American Cancer Society Cohort Study inquired about duration and frequency of use of multivitamins and single supplements of vitamins A, C and E (19) whereas the Continuing Survey of Food Intake in Individuals collected data on the frequency of multivitamins, multivitamins with minerals, and 13 single supplements (20). The Womens Health Initiative uses a detailed inventory system to collect dose, frequency and duration data on supplements that are of interest to its scientific objectives (e.g., calcium) (18). Participants in a large cohort of supplement users in western Washington State complete a detailed seven-page booklet on frequency, dose and duration for multivitamins, multivitamins with minerals (including specialty types such as antioxidant or "stress-type mixtures"), single supplements, herbs, and food derivatives, such as garlic and fish oil (21). Other studies have gathered information on the brand name of supplements used by participants (22,23). Clearly, methods for collection of dietary supplement data are not standardized and only a few investigators have conducted validity studies of methods used to assess supplement intake (18,21). The authors of one of these validity studies concluded that many commonly used methods for obtaining dietary supplement data have substantial amounts of error, and these authors called for more careful design of supplement assessment instruments to reduce the possibility of measurement error and attenuation of relative risk estimates in studies with disease endpoints (17).
There are other methodological issues concerning collection of dietary supplement data. First, protocols that only record the brand name of the supplement may misclassify dosages of nutrients assigned to study participants; formulations of the same product by the same manufacturer change over time so that recording a brand name only will not ensure consistent product content. Second, content and dose information cannot be obtained for most botanicals because there are no product specification standards for herbs and other supplements (9,10). For example, for a product labeled echinacea, the manufacturer is not required to indicate whether the product was derived from the flower, leaf, stem or root, each of which has different bioactive or marker compounds (24). Third, use of many herbs (e.g., echinacea) and single supplements (e.g., vitamin C) fluctuates according to menstrual cycle symptoms, illnesses such as colds and flu or general stress levels. Questionnaires or interview protocols that only inquire about frequency of use in the past month or year, but not the past week, may not capture this sporadic use.
Although occasional use is not likely to be important for chronic disease risk assessment, there are critical time periods in a womans life when acute exposure to a nutrient or substance may have important beneficial or adverse consequences. For example, exposure to the herb feverfew in pregnancy has been associated with an increased risk of spontaneous abortion, and black cohosh and blue cohosh can stimulate uterine contractions, which could be detrimental in early or midpregnancy (25,26). Lack of exposure to folic acid during a narrow but critical period of embryonic development (2628 d gestation) can result in a neural tube defect (27) whereas excessive vitamin A in early pregnancy is teratogenic (28).
Tens of thousands of products are sold in the United States, each with a different combination of micronutrients, botanicals and other ingredients. Construction and management of a useable database to incorporate such data into analysis is being used in one large dietary intervention study (23), but most studies have neither the resources nor the database expertise for such an endeavor. Efforts to construct a national database that could be available to all researchers in this area could greatly benefit the scientific community.
| Patterns of supplement use |
|---|
|
|
|---|
| Supplements used to maintain health |
|---|
|
|
|---|
| Supplements used to prevent disease or condition |
|---|
|
|
|---|
Several intervention studies have tested the effectiveness of specific supplements to prevent certain diseases or conditions. For example, at least 35 randomized-controlled trials have shown that supplemental calcium or calcium-vitamin D combinations increase bone mass and decrease fracture risk in adult females (38). Additionally, numerous observational studies have shown associations of dietary supplement use with reduced risk of cardiovascular disease, signs of aging, cognitive decline, affective disorders and some cancers (39,40). However, very little is known about whether the decision to use specific supplements is based on these published observations.
| Supplements used to treat disease or condition |
|---|
|
|
|---|
Weight management is a health concern of primary importance to American women, and thus it is not surprising that dietary supplements are used together with other measures such as exercise and dietary modifications. Levy et al. (41) reported results from a population-based telephone survey that showed that 71% of the women interviewed reported current attempts to lose weight. Of these women, 33% used vitamin and mineral supplements as part of their weight loss program. Results from NHANES III showed that specific supplements (kelp, lecithin and vitamin B-12) were used as weight loss aids (12). The 1998 Behavioral Risk Factor Surveillance System survey found that 48% of 8546 female respondents were overweight or obese (42). Ephedra products, which are classified as dietary supplements by DSHEA, were reportedly used by about 2% of these women as their primary weight loss tool.
Anecdotal evidence suggests that women use supplements to treat two common premenopausal conditions: benign breast disease and premenstrual syndrome. Although data to support efficacy are inconclusive, vitamin E, evening primrose oil and vitamin B-6 are often used to treat the symptoms of benign breast disease (43). Calcium, magnesium, vitamin B-6, vitamin E, St. Johns wort, kava and evening primrose oil are reportedly used to treat a variety of symptoms associated with premenstrual syndrome (44). However, no population-based prevalence data show the proportion of women who routinely use these supplements to self-treat these specific conditions.
Several studies have investigated associations of supplement use and breast cancer treatment. Newman et al. (23) reported that of 435 women diagnosed with breast cancer, 81% used multiple vitamin, mineral and herbal products. In another study of women with breast cancer, Burstein et al. (45) reported that 9% of the patients began the use of megavitamins or herbals after their breast cancer diagnosis, and the Womens Physicians Health Study found that women diagnosed with breast cancer were 1.5 times more likely to use supplements than were women without breast cancer (46). Patterson et al. (47) recently reported that there were statistically significant positive associations between receiving multiple medical treatments for breast or colon cancer and new use of dietary supplements after diagnosis. The results from these studies suggest that women who have a potentially life-threatening illness, such as cancer, are heavy users of dietary supplements, but the specific beliefs about these products and associations with long-term outcome have not been well characterized.
| Motivations for use of dietary supplements |
|---|
|
|
|---|
| Costs of dietary supplements |
|---|
|
|
|---|
| Conclusions and future research recommendations |
|---|
|
|
|---|
A focused research agenda on dietary supplements, which includes collaboration among the National Institutes of Health, academic scientists and industry partners, will provide data to help answer scientific questions with important public health implications.
| FOOTNOTES |
|---|
3 Abbreviations used: BDSHEA, Dietary Supplement and Health Education Act; FDA, U.S. Food and Drug Administration; NHANES III, third National Health and Nutrition Examination Survey. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Subar, A. F. & Block, G. (1990) Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. The 1987 Health Interview Survey. Am. J. Epidemiol. 132:1091-1101.
2. Slesinski, M. J., Subar, A. F. & Kahle, L. L. (1996) Dietary intake of fat, fiber and other nutrients is related to the use of vitamin and mineral supplements in the United States: the 1992 National Health Interview Survey. J. Nutr. 126:3001-3008.
3. Slesinski, M. J., Subar, A. F. & Kahle, L. L. (1995) Trends in the use of vitamin and mineral supplements in the United States: the 1987 and 1992 National Health Interview Surveys. J. Am. Diet. Assoc. 95:921-923.[Medline]
4. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M. & Kessler, R. C. (1998) Trends in alternative medicine use in the United States, 19901997. JAMA 280:1569-1575.
5. Ervin, R. B., Wright, J. D. & Kennedy-Stephenson, J. (1999) Use of dietary supplements in the United States, 19881994. Vital and Health Statistics- Series 11: Data from the National Health Survey i-iii:1-14.
6. Institute of Medicine (1998) Dietary Reference Intake: Folate, other B vitamins and choline 1998 National Academy Press Washington D. C.
7. Beard, J. C. (2000) Effectiveness of strategies of iron supplementation during pregnancy. Am. J. Clin. Nutr. 71:1288S-1294S.
8. Allen, L. H. (2002) Iron supplementation: scientific issues concerning efficacy and implications for research and programs. J. Nutr 132:813S-819S.
9. Public Law 103417, 103rd Congress. Dietary Supplement and Health Education Act of 1994 October 25, 1994.
10. Costello, R. B. & Coates, P. (2001) In the midst if confusion lies the opportunity: fostering quality science in dietary supplement research. J. Am. Coll. Nutr. 20:21-25.
11. Hankin, J. (2000) Keeping up with the increasing popularity of nonvitamin, nonmineral supplements. J. Am. Diet. Assoc. 100:419-420.[Medline]
12. Radimer, K. L., Subar, A. F. & Thompson, F. E. (2000) Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. J. Am. Diet. Assoc. 100:447-454.[Medline]
13. Block, G., Cox, C., Madans, J., Schreiber, G. B., Licitra, L. & Melia, N. (1988) Vitamin supplement use by demographic characteristics. Am. J. Epidemiol. 127:297-309.
14. Kushi, L. H., Fee, R. M., Sellers, T. A., Zheng, W. & Folsom, A. R. (1996) Intake of vitamins A, C and E in postmenopausal breast cancer. Am. J. Epidemiol. 144:165-174.
15. Bender, M. M., Levy, A. S., Schuker, R. E. & Yetley, E. A. (1992) Trends in prevalence and magnitude of vitamin and mineral supplement usage and correlation with health status. J. Am. Diet. Assoc. 92:1096-1101.[Medline]
16. Armstrong, B. K., White, E. & Saracci, R. (1994) Principles of exposure measurement in epidemiology. Monographs in epidemiology and biostatistics Vol 21 Oxford University Press Oxford .
17. Patterson, R. E., Kristal, A. R., Levy, L., McLerran, D. & White, E. (1998) Validity of methods used to assess vitamin and mineral supplement use. Am. J. Epidemiol. 148:643-649.
18. Patterson, R. E., Levy, L., Tinker, L. F. & Kristal, A. R. (1999) Evaluation of a simplified vitamin supplement inventory developed for the Womens Health Initiative. Pub. Health Nutr. 2:273-276.
19. Jacobs, E. J., Connell, C. J., Patel, A. V., Chao, A., Rodriguez, C., Seymour, J., McCullough, M. L., Calle, E. E. & Thun, M. J. (2001) Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society Cohort. Cancer Epidemiol. Biomark. Prev. 10:17-23.
20. Stang, J., Story, M. T., Harnack, L. & Neumark-Sztainer, D. (2000) Relationships between vitamin and mineral supplement use, dietary intake, and dietary adequacy among adolescents. J. Am. Diet. Assoc. 100:905-910.[Medline]
21. Satia-Abouta, J., Patterson, R. E., King, I. B., Stratton, K. L., Shattuck, A. L., Kristal, A. R., Potter, J. D., Thornquist, M. D. & White, E. (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the VITamins And Lifestyle (VITAL) Study. Am. J. Epidemiol. 157:944-954.
22. Hunter, D. J., Manson, J. E., Colditz, G. A., Stampfer, M. J., Rosner, B., Hennekens, C. H., Speizer, F. E. & Willett, W. C. (1993) A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 329:234-240.
23. Newman, V., Rock, C. L., Faerber, S., Flatt, S. W., Wright, F. A. & Pierce, J. P. (1998) Dietary supplement use by women at risk for breast cancer recurrence. J. Am. Diet. Assoc. 98:285-292.[Medline]
24. Perry, N. B., Burgess, E. J. & Glennie, V. L. (2001) Echinacea standardization: analytical methods for phenolic compounds and typical levels in medicinal species. J. Agric Food Chem. 49:1702-1706.[Medline]
25. Hepner, D. L., Harnett, M., Segal, S., Camann, W., Bader, A. M. & Tsen, L. C. (2002) Herbal medicine use in parturients. Anesth. Analg. 94:690-693.
26. Conover, E. A. (2002) Over-the-counter products: nonprescription medications, nutriceuticals, and herbal agents. Clin. Obstet. Gynecol. 45:89-98.[Medline]
27. Centers for Disease Control and Prevention (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects 1992:1-14MMWR 41: no. RR-14:.
28. Rothman, K. J., Moore, L. L., Singler, M. R., Nguyen, U. S., Mannino, S. & Milunsky, A. (1995) Teratogenicity of high vitamin A. N. Engl. J. Med. 333:1369-1373.
29. Lyle, B. J., Mares-Perlman, J. A., Klein, B.E.K., Klein, R. & Greger, J. L. (1998) Supplement users differ from non-users in demographic, lifestyle and health characteristics. J Nutr 128:2355-2362.
30. Kirk, S.F.L., Cade, J. E., Barrett, J. H. & Conner, M. (1999) Diet and lifestyle characteristics associated with dietary supplement use in women. Pub. Health Nutr. 2:69-73.
31. White, E., Shannon, J. S. & Patterson, R. E. (1997) Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol. Biomark. Prev 6:769-774.
32. Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E. & Mitchell, A. A. (2002) Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 287:337-344.
33. Eldridge, A. L. & Sheenan, E. T. (1994) Food supplement use and related beliefs: survey of community college students. J. Nutr. Educ. 26:259-265.
34. Perkin, J. E., Wilson, W. J., Schuster, K., Rodriguez, J. & Allen-Chabot, A. (2002) Prevalence of nonvitamin, nonmineral supplement usage among university students. J. Am. Diet.. Assoc 102:412-414.[Medline]
35. Centers for Disease Control and Prevention (1999) Knowledge and use of folic acid by women of childbearing age-United States, 1995 and 1998. MMWR 48:325-327.[Medline]
36. Kloeblen, A. S. (1999) Folate knowledge, intake from fortified grain products, and periconceptional supplementation patterns of a sample of low-income pregnant women according to the Health Belief Model. J. Am. Diet. Assoc. 99:33-38.[Medline]
37. Perez-Escamilla, R., Himmelgreen, D., Segura-Millan, S., Gonzalez, A., Mendez, I. & Haldman, L. (1999) Knowledge of folic acid and neural tube defects among inner-city residents: have they heard about it?. J. Am. Diet. Assoc. 99:80-83.[Medline]
38. Heany, R. P. (2000) Calcium, dairy products and osteoporosis. J. Am. Coll. Nutr. 19:83S-99S.
39. Patterson, R. E., White, E., Kristal, A. R., Neuhouser, M. L. & Potter, J. D. (1997) Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control 8:786-802.[Medline]
40. Hercberg, S., Galan, P., Preziosi, P., Alfarez, M. J. & Vazquez, C. (1998) The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers. Nutrition 14:513-520.[Medline]
41. Levy, A. S. & Heaton, A. W. (1993) Weight control practices of US adults trying to lose weight. Ann. Intern. Med. 119:661-666.
42. Blanck, H. M., Khan, L. K. & Serdula, M. K. (2001) Use of non-prescription weight loss products. Results from a multistate survey. JAMA 286:930-935.
43. Horner, N. K. & Lampe, J. W. (2000) Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence for effectiveness. J. Am. Diet. Assoc. 100:1368-1380.[Medline]
44. Bendich, A. (2000) The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J. Am. Coll. Nutr. 19:3-12.
45. Burstein, H. J., Gelber, S., Guadagnoli, E. & Weeks, J. C. (1999) Use of alternative medicine by women with early stage breast cancer. N. Engl. Med. 340:1733-1739.
46. Frank, E., Bendich, A. & Denniston, M. (2000) Use of vitamin-mineral supplements by female physicians in the United States. Am. J. Clin. Nutr. 72:969-975.
47. Patterson, R. E., Neuhouser, M. L., Hedderson, M. M., Schwartz, S. M., Standish, L. J., Bowen, D. J. & Marshall, L. M. (2002) Types of alternative medicine use by breast, colon and prostate cancer patients: predictors, motives and costs. J Alt Comp Med 8:477-485.[Medline]
48. Neuhouser, M. L., Patterson, R. E. & Levy, L. (1999) Motivations for using vitamin and mineral supplements. J. Am. Diet. Assoc. 99:851-854.[Medline]
49. Conner, M., Kirk, S.F.L., Cade, J. E. & Barrett, J. H. (2001) Why do women use dietary supplements? The use of the theory of planned behavior to explore beliefs about their use. Social Sci. Med. 52:621-633.
50. Nesheim, M. C. (1999) What is the research base for the use of dietary supplements?. Pub. Health Nutr. 2:35-38.
51. Tucker, L. A. & Clegg, A. G. (2002) Differences in health care costs and utilization among adults with selected lifestyle-related risk factors. Am. J. Health Prom. 16:225-233.[Medline]
52. Max, W. (2001) The financial impact of smoking on health-related costs: a review of the literature. Am. J Health Prom. 15:321-331.[Medline]
This article has been cited by other articles:
![]() |
M. L. Neuhouser, S. Wassertheil-Smoller, C. Thomson, A. Aragaki, G. L. Anderson, J. E. Manson, R. E. Patterson, T. E. Rohan, L. van Horn, J. M. Shikany, et al. Multivitamin Use and Risk of Cancer and Cardiovascular Disease in the Women's Health Initiative Cohorts Arch Intern Med, February 9, 2009; 169(3): 294 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Catov, L. M. Bodnar, R. B. Ness, N. Markovic, and J. M. Roberts Association of Periconceptional Multivitamin Use and Risk of Preterm or Small-for-Gestational-Age Births Am. J. Epidemiol., August 1, 2007; 166(3): 296 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardia, N. L. Nisly, M. B. Zimmerman, B. M. Gryzlak, and R. B. Wallace Use of Herbs Among Adults Based on Evidence-Based Indications: Findings From the National Health Interview Survey Mayo Clin. Proc., May 1, 2007; 82(5): 561 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mejia-Rodriguez, D. Sotres-Alvarez, L. M. Neufeld, A. Garcia-Guerra, and C. Hotz Use of Nutritional Supplements among Mexican Women and the Estimated Impact on Dietary Intakes below the EAR and above the UL J. Am. Coll. Nutr., February 1, 2007; 26(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A Yetley Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions Am. J. Clinical Nutrition, January 1, 2007; 85(1): 269S - 276S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L Rock Multivitamin-multimineral supplements: who uses them? Am. J. Clinical Nutrition, January 1, 2007; 85(1): 277S - 279S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bardia, D. L. Barton, L. J. Prokop, B. A. Bauer, and T. J. Moynihan Efficacy of Complementary and Alternative Medicine Therapies in Relieving Cancer Pain: A Systematic Review J. Clin. Oncol., December 1, 2006; 24(34): 5457 - 5464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes Diabetes Care, August 1, 2006; 29(8): 1826 - 1832. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||